{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:31:24Z","timestamp":1787495484927,"version":"build-2736575974"},"reference-count":58,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T00:00:00Z","timestamp":1553212800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100003975","name":"Myotonic Dystrophy Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003975","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RF-2010-2314711"],"award-info":[{"award-number":["RF-2010-2314711"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["Ricerca Corrente"],"award-info":[{"award-number":["Ricerca Corrente"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fondazione Malattie Miotoniche","award":["None"],"award-info":[{"award-number":["None"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0214254","type":"journal-article","created":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T13:29:14Z","timestamp":1553261354000},"page":"e0214254","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":29,"title":["Aberrant insulin receptor expression is associated with insulin resistance and skeletal muscle atrophy in myotonic dystrophies"],"prefix":"10.1371","volume":"14","author":[{"given":"Laura Valentina","family":"Renna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Bos\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Brigonzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Fossati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Meola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8858-4327","authenticated-orcid":true,"given":"Rosanna","family":"Cardani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,3,22]]},"reference":[{"key":"ref1","article-title":"Myotonic Dystrophy","author":"PS Harper","year":"2001"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.bbadis.2014.05.019","article-title":"Myotonic dystrophies: An update on clinical aspects, genetic, pathology, and molecular pathomechanisms","volume":"1852","author":"G Meola","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0092-8674(92)90154-5","article-title":"Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3\u2019end of a transcript encoding a protein kinase family member","volume":"69","author":"JD Brook","year":"1992","journal-title":"Cell"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1126\/science.1546326","article-title":"An unstable triplet repeat in a gene related to myotonic muscular dystrophy","volume":"255","author":"YH Fu","year":"1992","journal-title":"Science"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1126\/science.1546325","article-title":"Myotonic dystrophy mutation: an unstable CTG repeat in the 3\u2019 untranslated region of the gene","volume":"255","author":"M Mahadevan","year":"1992","journal-title":"Science"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1126\/science.1062125","article-title":"Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9","volume":"293","author":"CL Liquori","year":"2001","journal-title":"Science"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1097-2765(02)00572-5","article-title":"Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing","volume":"10","author":"N Charlet-B","year":"2002","journal-title":"Mol Cell"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nm.2374","article-title":"Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy","volume":"17","author":"C Fugier","year":"2011","journal-title":"Nat Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1097-2765(02)00563-4","article-title":"Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy","volume":"10","author":"A Mankodi","year":"2002","journal-title":"Mol Cell"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/ng704","article-title":"Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy","volume":"29","author":"RS Savkur","year":"2001","journal-title":"Nat Genet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1086\/421528","article-title":"Insulin receptor splicing alteration in myotonic dystrophy type 2","volume":"74","author":"RS Savkur","year":"2004","journal-title":"Am J Hum Genet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3390\/genes4020275","article-title":"Altered Ca2+ homeostasis and endoplasmic reticulum stress in myotonic dystrophy type 1 muscle cells","volume":"4","author":"A Botta","year":"2013","journal-title":"Genes"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e0184987","DOI":"10.1371\/journal.pone.0184987","article-title":"Receptor and post-receptor abnormalities contribute to insulin resistance in myotonic dystrophy type 1 and type 2 skeletal muscle","volume":"12","author":"LV Renna","year":"2017","journal-title":"PLoS One"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1034\/j.1600-0838.2003.20235.x","article-title":"Ageing and local growth factors in muscle","volume":"13","author":"SDR Harridge","year":"2003","journal-title":"Scandinavian Journal of Medicine and Science in Sports"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/2044-5040-1-4","article-title":"Regulation of skeletal muscle growth by the IGF1-Akt\/PKB pathway: insights from genetic models","volume":"1","author":"F Schiaffino","year":"2011","journal-title":"Skeletal Muscle"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/ana.410170115","article-title":"In vivo estimation of muscle protein synthesis in myotonic dystrophy","volume":"17","author":"D Halliday","year":"1985","journal-title":"Ann Neurol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3389\/fneur.2018.00368","article-title":"Abnormalities in skeletal muscle myogenesis, growth, and regeneration in myotonic dystrophy","volume":"9","author":"LM Andr\u00e9","year":"2018","journal-title":"Front Neurol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.nbd.2010.01.017","article-title":"Proteome profile in Myotonic Dystrophy type 2 myotubes reveals dysfunction in protein processing and mitochondrial pathways","volume":"38","author":"F Rusconi","year":"2010","journal-title":"Neurobiol Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.2337\/db05-0853","article-title":"Insulin signalling and glucose transport in skeletal muscle from first-degree relatives of type 2 diabetic patients","volume":"55","author":"HKR Karlsson","year":"2006","journal-title":"Diabetes"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.molmet.2013.10.005","article-title":"Muscle insulin sensivity and glucose metabolism are controlled by the intrinsic muscle clock","volume":"3","author":"K Dyar","year":"2014","journal-title":"Molecular Metabolism"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3389\/fphys.2018.00358","article-title":"Exercise protects against defective insulin signaling and insulin resistance of glucose transport in skeletal muscle of angiotensin II-infused rat","volume":"9","author":"J. Surapongchai","year":"2018","journal-title":"Front Physiol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0960-8966(01)00284-X","article-title":"Report of the 84th ENMC workshop: PROMM (proximal myotonic myopathy) and other myotonic dystrophy-like syndromes: 2nd workshop. 13-15th October 2000, Loosdrecht: The Netherlands","volume":"12","author":"RT Moxley","year":"2002","journal-title":"Neuromuscul Disord"},{"key":"ref23","first-page":"958510","article-title":"Identification and characterization of DM1 patients by a new diagnostic certified assay: neuromuscular and cardiac assessments","author":"R Valaperta","year":"2013","journal-title":"Biomed Res Int"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1089\/gtmb.2015.0135","article-title":"Development and validation of a new molecular diagnostic assay for detection of myotonic dystrophy type 2","volume":"19","author":"R Valaperta","year":"2015","journal-title":"Genet Test Mol Biomarkers"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"437","DOI":"10.4081\/918","article-title":"Biomolecular identification of (CCTG)n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy","volume":"48","author":"R Cardani","year":"2004","journal-title":"Eur J Histochem"},{"key":"ref26","article-title":"Muscle biopsy. A practical approach","author":"V. Dubowitz","year":"1985"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1212\/01.WNL.0000065898.61358.09","article-title":"Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM\/DM2","volume":"60","author":"A Vihola","year":"2003","journal-title":"Neurology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1212\/WNL.56.3.336","article-title":"Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy","volume":"56","author":"J Mathieu","year":"2001","journal-title":"Neurology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/ana.410270509","article-title":"Mechanism of muscle wasting in myotonic dystrophy","volume":"27","author":"RC Griggs","year":"1990","journal-title":"Ann Neurol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"C1132","DOI":"10.1152\/ajpcell.1999.276.5.C1132","article-title":"Evaluation of signals activating ubiquitin-proteasome proteolysis in a model of muscle wasting","volume":"276","author":"WE Mitch","year":"1999","journal-title":"Am J Physiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"14440","DOI":"10.1073\/pnas.251541198","article-title":"Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy","volume":"98","author":"MD Gomes","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1126\/science.1065874","article-title":"Identification of ubiquitin ligases required for skeletal muscle atrophy","volume":"294","author":"SC Bodine","year":"2001","journal-title":"Science"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1172\/JCI89616","article-title":"Targeting deregulated AMPK\/Mtorc1 patwhays improves muscle function in myotonic dystrophy type 1","volume":"127","author":"M Brockhoff","year":"2017","journal-title":"J Clin Invest"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1210\/endo.140.9.7057","article-title":"Insulin-like growth factor I circumvents defective insulin action in human myotonic dystrophy skeletal muscle cells","volume":"140","author":"D Furling","year":"1999","journal-title":"Endocrinology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"13570","DOI":"10.1073\/pnas.1308806110","article-title":"Reexpression of pyruvate kinase M2 in type 1 myofibers correlates with altered glucose metabolism in myotonic dystrophy","volume":"110","author":"Z Gao","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1073\/pnas.78.4.2567","article-title":"Abnormal regulation of monocyte insulin-binding affinity after glucose ingestion in patients with myotonic dystrophy","volume":"78","author":"RT Moxley","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1172\/JCI119332","article-title":"RNA metabolism in myotonic dystrophy","volume":"99","author":"A Morrone","year":"1997","journal-title":"J Clin Invest"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1210\/jc.2012-3876","article-title":"Slow-twitch fiber proportion in skeletal muscle correlates with insulin responsiveness","volume":"98","author":"CA Stuart","year":"2013","journal-title":"J Clin Endocrinol Metabol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s00424-003-1195-8","article-title":"Muscle- and fiber type-specific expression of glucose transporter 4, glycogen synthase and glycogen phosphorylase proteins in human skeletal muscle","volume":"447","author":"JR Daugaard","year":"2004","journal-title":"Eur J Physiol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2337\/db14-0590","article-title":"Human muscle fiber type-specific insulin signaling: impact of obesity and type 2 diabetes","volume":"64","author":"PH Albers","year":"2015","journal-title":"Diabetes"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1021\/bi00134a008","article-title":"Distinct -subunit structures of human insulin receptor A and B variants determine differences in tyrosine kinase activities","volume":"31","author":"M Kellerer","year":"1992","journal-title":"Biochemistry"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"20816","DOI":"10.1074\/jbc.270.35.20816","article-title":"The B isoform of the insulin receptor signals more efficiently than the A isoform in HepG2 cells","volume":"270","author":"A Kosaki","year":"1995","journal-title":"J Biol Chem"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.2337\/db06-0150","article-title":"Distinct signals regulate AS160 phosphorylation in response to insulin, AICAR, and contraction in mouse skeletal muscle","volume":"55","author":"HF Kramer","year":"2006","journal-title":"Diabetes"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1210\/me.2005-0476","article-title":"Interaction of the Akt substrate, AS160, with the GLUT4 vesicle marker protein, IRAP","volume":"20","author":"GR Peck","year":"2006","journal-title":"Mol Endocrinol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"14599","DOI":"10.1074\/jbc.C300063200","article-title":"Insulin-stimulated phosphorylation of a Rab GTPase activating protein regulates GLUT4 translocation","volume":"278","author":"H Sano","year":"2003","journal-title":"J Biol Chem"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"E401","DOI":"10.1152\/ajpendo.00542.2007","article-title":"The effect of exercise and insulin on AS160 phosphorylation and 14-3-3 binding capacity in human skeletal muscle","volume":"294","author":"KF Howlett","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1002\/1097-4598(200012)23:12<1789::AID-MUS2>3.0.CO;2-4","article-title":"Clinical and genetic heterogeneity in myotonic dystrophies","volume":"23","author":"G. Meola","year":"2000","journal-title":"Muscle Nerve"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"C392","DOI":"10.1152\/ajpcell.00125.2016","article-title":"The ubiquitin proteasome system in atrophying skeletal muscle: roles and regulation","volume":"311","author":"PA Bilodeau","year":"2016","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1097-2765(04)00211-4","article-title":"The IGF-1\/PI3K\/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors","volume":"14","author":"TN Stitt","year":"2004","journal-title":"Mol Cell"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0092-8674(04)00400-3","article-title":"Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy","volume":"117","author":"M Sandri","year":"2004","journal-title":"Cell"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1096\/fj.11-189977","article-title":"Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy","volume":"26","author":"SA Reed","year":"2012","journal-title":"FASEB J"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ncb1101-1014","article-title":"Akt\/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo","volume":"3","author":"SC Bodine","year":"2001","journal-title":"Nat Cell Biol"},{"key":"ref53","first-page":"94","article-title":"Muscle atrophy in patients with type 2 diabetes mellitus: roles of inflammatory pathways, physical activity and exercise","volume":"22","author":"BD Perry","year":"2016","journal-title":"Exerc Immunol Rev"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/j.biocel.2010.08.010","article-title":"Altered signal transduction pathways and induction of autophagy in human myotonic dystrophy type 1 myoblasts","volume":"42","author":"P Beffy","year":"2010","journal-title":"Int J Biochem Cell Biol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1242\/jcs.116285","article-title":"mTOR-dependent proliferation defect in human ES-derived neural stem cells affected by myotonic dystrophy type 1","volume":"126","author":"JA Denis","year":"2013","journal-title":"J Cell Sci"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"748","DOI":"10.2353\/ajpath.2009.090047","article-title":"Expression of RNA CCUG repeats dysregulates translation and degradation of proteins in myotonic dystrophy 2 patients","volume":"175","author":"E Salisbury","year":"2009","journal-title":"Am J Pathol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/cdd.2010.33","article-title":"Normal myogenesis and increased apoptosis in myotonic dystrophy type-1 muscle cells","volume":"17","author":"E Loro","year":"2010","journal-title":"Cell Death Differ"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1242\/dmm.018127","article-title":"Increased autophagy and apoptosis contribute to muscle atrophy in a myotonic dystrophy type 1 Drosophila model","volume":"8","author":"A Bargiela","year":"2015","journal-title":"Dis Model Mech"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0214254","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T16:09:10Z","timestamp":1588954150000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0214254"}},"subtitle":[],"editor":[{"given":"Makoto","family":"Kanzaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,3,22]]},"references-count":58,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,3,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0214254","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,22]]}}}